For instance, patients who were diagnosed with both hypertension and type 2 DM were treated with calcium channel blockers, whereas guidelines suggest that they should be treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers because of nephroprotective action. Here, ACE is linked to hypertensive disorder.